🔗 Share this article

An underground economy for unapproved slimming medications is being driven by social media fitness personalities and vendors on messaging platforms, based on recent findings.

Experimental Drug Gaining Popularity Via Social Media

Retatrutide, which is still in research studies, is being advertised by social media influencers for its alleged fat-burning effects. Followers are encouraged to contact these accounts privately for source information, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Additionally, a flourishing trade exists on messaging services, where communities with numerous of members share “before and after” images, administration instructions and assertions of next-day UK delivery. Sellers promote the drug there before redirecting buyers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an experimental injection developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could assist patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.

Medical Professionals Voice Worries

Nevertheless, doctors and chemists have warned that the distribution of what is still an unapproved drug in the United Kingdom is a cause for concern and could lead to individuals administering substances of unknown origin.

Several experts stated the demand for the experimental drug could be connected to the increasing cost of approved weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the British medical regulations.

Several influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still breach medicines, marketing, and customer regulations, risking fines, legal action or prison.

Platform Reaction and Material Removal

According to TikTok, the service has taken down problematic material and prohibited associated hashtags and query recommendations. The company said it was committed to maintaining the platform secure and allocating resources in strengthening compliance measures.

Online Marketplace Operations

Investigations also found communities with up to 9,000 participants marketing the experimental drug using Telegram's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” immediately displays groups with thousands of members, filled with images of slimming results, positive reviews and step-by-step instructions for mixing or administering at home.

Within minutes of joining one community, a vendor shared contact information, where most transactions take place. The vendor sent an instruction manual and guaranteed shipping within two days. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about body mass, medical conditions or past usage.

Product Information and Costs

Within these communities, messages show black plastic parcels with Royal Mail labels, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with purified liquid, or ready-to-use injectors usually sold at £160 for 20mg. When questioned how long a injector should last, vendors give conflicting responses varying between a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A spokesperson for Telegram said it regularly moderated dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are administering substances they can’t verify. Even if the research behind retatrutide is valid, these digital versions may not include what they claim,” said Jason Murphy, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the surge in demand to recent price rises for authorized weight-loss drugs such as Mounjaro. “With costs rising, individuals are using online platforms. But fake treatments are extremely risky. You cannot know what’s inside or whether the environment they were made in was sterile,” she explained.

Her staff has previously encountered patients injured by self-injection from unverified sources. “We understand the frustration, but buying from Telegram or WhatsApp is taking chances with your well-being,” stated Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company experimental product not yet approved … may expose users to potentially serious health risks”.